Ariel T. Levy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ariel T. Levy has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Huda B. Al-Kouatly
Division of Maternal‐Fetal Medicine Sidney Kimmel Medical College at Thomas Jefferson University Philadelphia Pennsylvania USA
3 shared publications Johanna Quist-Nelson
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC (Dr Quist-Nelson)
3 shared publicationsVincenzo Berghella
Department of Obstetrics and Gynecology, Division of Maternal‐Fetal Medicine Thomas Jefferson University Hospital Philadelphia Pennsylvania USA
2 shared publications- Vincenzo Berghella
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA
2 shared publications - Amelie Pham
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, USA
1 shared publication - Antonio F. Saad
Department of Maternal Fetal Medicine, Inova Fairfax Hospital, Falls Church, USA
1 shared publication
Latest Publications
- Open Access
- 1 August 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 168 (1) , 35-42
Recombinant erythropoietin for the treatment of iron deficiency anemia in pregnancy: A systematic review
Background: Treatment options for severe, refractory iron deficiency anemia are limited in pregnancy.Objective: To review the available literature on the use of recombinant erythropoietin in the treatment of iron deficiency anemia in pregnancy.Search Strategy: An electronic search of seven databases from inception to March 2022 was performed using a combination of keywords.Selection Criteria: We included all randomized controlled or observational studies of pregnant patients with iron deficiency anemia who received recombinant erythropoietin or control. The primary outcome was a change in hematologic parameters (hemoglobin or hematocrit) after treatment. Studies were appraised using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions.Data Collection and Analysis: Data were summarized using narrative synthesis and descriptive statistics as appropriate. This study was registered with PROSPERO, CRD42022313328.Main Results: Of 234 studies screened, five studies met the inclusion criteria and had sufficient data for analysis (n = 103 recombinant erythropoietin and n = 104 controls). All patients in the intervention group received iron supplementation (intravenous or oral) in addition to recombinant erythropoietin. All patients in the control group received iron supplementation (intravenous or oral) alone. As the result of variance between studies in inclusion criteria, the timing of repeat blood draws, and data reporting, a meta‐analysis could not be performed. Three studies found that serial recombinant erythropoietin combined with iron supplementation was more effective at raising hematologic laboratory parameters (hemoglobin or hematocrit) than iron alone. One study reported no difference in hemoglobin or hematocrit levels between groups at day 28. However, patients in this study only received one dose of recombinant erythropoietin, whereas those in the other studies received serial doses. Another study also found no difference in hemoglobin levels by day 28, but patients in the recombinant erythropoietin group had lower hemoglobin levels at baseline and a more rapid rise in hemoglobin than iron alone. This is demonstrated by a more significant rise in hemoglobin at day 11 in the recombinant erythropoietin group than in the control group.Conclusions: Serial recombinant erythropoietin administration and iron supplementation may be more effective at treating refractory iron deficiency anemia in pregnancy than iron supplementation alone.
- 1 August 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 168 (1) , 35-42
Open AccessRecombinant erythropoietin for the treatment of iron deficiency anemia in pregnancy: A systematic review
Background: Treatment options for severe, refractory iron deficiency anemia are limited in pregnancy.Objective: To review the available literature on the use of recombinant erythropoietin in the treatment of iron deficiency anemia in pregnancy.Search Strategy: An electronic search of seven databases from inception to March 2022 was performed using a combination of keywords.Selection Criteria: We included all randomized controlled or observational studies of pregnant patients with iron deficiency anemia who received recombinant erythropoietin or control. The primary outcome was a change in hematologic parameters (hemoglobin or hematocrit) after treatment. Studies were appraised using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions.Data Collection and Analysis: Data were summarized using narrative synthesis and descriptive statistics as appropriate. This study was registered with PROSPERO, CRD42022313328.Main Results: Of 234 studies screened, five studies met the inclusion criteria and had sufficient data for analysis (n = 103 recombinant erythropoietin and n = 104 controls). All patients in the intervention group received iron supplementation (intravenous or oral) in addition to recombinant erythropoietin. All patients in the control group received iron supplementation (intravenous or oral) alone. As the result of variance between studies in inclusion criteria, the timing of repeat blood draws, and data reporting, a meta‐analysis could not be performed. Three studies found that serial recombinant erythropoietin combined with iron supplementation was more effective at raising hematologic laboratory parameters (hemoglobin or hematocrit) than iron alone. One study reported no difference in hemoglobin or hematocrit levels between groups at day 28. However, patients in this study only received one dose of recombinant erythropoietin, whereas those in the other studies received serial doses. Another study also found no difference in hemoglobin levels by day 28, but patients in the recombinant erythropoietin group had lower hemoglobin levels at baseline and a more rapid rise in hemoglobin than iron alone. This is demonstrated by a more significant rise in hemoglobin at day 11 in the recombinant erythropoietin group than in the control group.Conclusions: Serial recombinant erythropoietin administration and iron supplementation may be more effective at treating refractory iron deficiency anemia in pregnancy than iron supplementation alone.
- 3 October 2023
- Published by Wiley in Prenatal Diagnosis
- Vol. 43 (11) , 1433-1441
Imaging and outcomes of fetal adrenal hemorrhage: A systematic review
Objective: To describe prenatal and postnatal imaging findings of fetal adrenal hemorrhage (FAH) and its associated perinatal outcomes, including frequency of postnatal surgical intervention. Method: A systematic literature review of seven electronic databases was conducted from inception until January 2022, with 2008 articles identified reporting prenatally identified fetal adrenal masses. Studies with confirmed FAH diagnosis were included. Quality and risk assessment were evaluated. Results: Thirty‐five studies, including 102 FAH cases, were analyzed. FAH was commonly described as cystic (28/90, 31%), anechoic (25/90, 28%), or mixed echogenic (14/90, 16%) on ultrasound. Outcome data were available for 65 cases (64%) of FAH: 9% (6/65) resolved prenatally, 35% (23/65) resolved postnatally, 34% (22/65) regressed in size after birth, and 22% (14/65) persisted postnatally. Overall, 25% (16/65) of cases underwent postnatal surgical intervention. Neuroblastoma was suspected in all 16 surgical cases. Only one case (1/16, 6%) confirmed a cystic hematoma with microscopic islets of neuroblastoma in situ on pathology. Conclusion: Prenatal diagnosis of FAH is challenging due to the significant heterogeneity of ultrasound findings. Final pathology did not support the need for surgical intervention. Persistent postnatal FAH warrants shared decision making for further management based on the clinical presentation.
- 3 October 2023
- Published by Wiley in Prenatal Diagnosis
- Vol. 43 (11) , 1433-1441
Imaging and outcomes of fetal adrenal hemorrhage: A systematic review
Objective: To describe prenatal and postnatal imaging findings of fetal adrenal hemorrhage (FAH) and its associated perinatal outcomes, including frequency of postnatal surgical intervention. Method: A systematic literature review of seven electronic databases was conducted from inception until January 2022, with 2008 articles identified reporting prenatally identified fetal adrenal masses. Studies with confirmed FAH diagnosis were included. Quality and risk assessment were evaluated. Results: Thirty‐five studies, including 102 FAH cases, were analyzed. FAH was commonly described as cystic (28/90, 31%), anechoic (25/90, 28%), or mixed echogenic (14/90, 16%) on ultrasound. Outcome data were available for 65 cases (64%) of FAH: 9% (6/65) resolved prenatally, 35% (23/65) resolved postnatally, 34% (22/65) regressed in size after birth, and 22% (14/65) persisted postnatally. Overall, 25% (16/65) of cases underwent postnatal surgical intervention. Neuroblastoma was suspected in all 16 surgical cases. Only one case (1/16, 6%) confirmed a cystic hematoma with microscopic islets of neuroblastoma in situ on pathology. Conclusion: Prenatal diagnosis of FAH is challenging due to the significant heterogeneity of ultrasound findings. Final pathology did not support the need for surgical intervention. Persistent postnatal FAH warrants shared decision making for further management based on the clinical presentation.
- 1 September 2021
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 3 (5) , 100399
Acceptance of COVID-19 vaccination in pregnancy: a survey study
- 1 September 2021
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 3 (5) , 100399
Acceptance of COVID-19 vaccination in pregnancy: a survey study
- 1 July 2021
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 3 (4) , 100346
Hands-and-knees posturing and fetal occiput anterior position: a systematic review and meta-analysis
- 1 July 2021
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 3 (4) , 100346
Hands-and-knees posturing and fetal occiput anterior position: a systematic review and meta-analysis
- 1 November 2020
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 2 (4) , 100170
The effect of transvaginal ultrasound, vaginal examination, or coitus on fetal fibronectin results: individual participant data from 6 cohort studies
- 1 November 2020
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 2 (4) , 100170
The effect of transvaginal ultrasound, vaginal examination, or coitus on fetal fibronectin results: individual participant data from 6 cohort studies
- 7 October 2020
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (1) , 26-32
Outcome of 45,X fetuses with cystic hygroma: A systematic review
This objective of this systematic review was to estimate live birth rate and explore prognostic indicators in fetuses with 45,X karyotype and a posterior cystic hygroma (CH). Electronic databases were searched and studies reporting pregnancy outcomes (termination, spontaneous abortion, demise, or live birth) for fetuses with 45,X karyotype and a CH diagnosed on ultrasound were included. For cases of survival, CH characteristics, presence of hydrops fetalis, or concomitant anomalies, delivery details, and postnatal outcomes were summarized. A total of 95 studies, including 535 cases, met inclusion criteria: 285 (53.3%) pregnancies were terminated, 72 (13.5%) had spontaneous abortion or demise, 164 (30.7%) had unspecified pregnancy failure, and 14 (2.6%) were live births. Among live births with data available, all CH measured 2–7 cm, more than half were septate, and almost all regressed in size or eventually disappeared. Hydrops fetalis was noted in five cases. Of the eight live births with neonatal outcomes available, three neonates died shortly after birth and five survived past the neonatal period. This review suggests that diagnosis of CH in a 45,X fetus is associated with an estimated live birth rate of 2.6%, but only 1% survive to infancy. Prognosis appears to improve with CH regression.
- 7 October 2020
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (1) , 26-32
Outcome of 45,X fetuses with cystic hygroma: A systematic review
This objective of this systematic review was to estimate live birth rate and explore prognostic indicators in fetuses with 45,X karyotype and a posterior cystic hygroma (CH). Electronic databases were searched and studies reporting pregnancy outcomes (termination, spontaneous abortion, demise, or live birth) for fetuses with 45,X karyotype and a CH diagnosed on ultrasound were included. For cases of survival, CH characteristics, presence of hydrops fetalis, or concomitant anomalies, delivery details, and postnatal outcomes were summarized. A total of 95 studies, including 535 cases, met inclusion criteria: 285 (53.3%) pregnancies were terminated, 72 (13.5%) had spontaneous abortion or demise, 164 (30.7%) had unspecified pregnancy failure, and 14 (2.6%) were live births. Among live births with data available, all CH measured 2–7 cm, more than half were septate, and almost all regressed in size or eventually disappeared. Hydrops fetalis was noted in five cases. Of the eight live births with neonatal outcomes available, three neonates died shortly after birth and five survived past the neonatal period. This review suggests that diagnosis of CH in a 45,X fetus is associated with an estimated live birth rate of 2.6%, but only 1% survive to infancy. Prognosis appears to improve with CH regression.
- 13 May 2020
- Published by Springer Nature in Journal of Immigrant and Minority Health
- Vol. 23 (1) , 45-53
Provider Knowledge and Attitudes About Female Genital Mutilation/Cutting in Philadelphia
Background Due to an increase in immigration from African countries, U.S. healthcare professionals are encountering women affected by Female Genital Mutilation/Cutting (FGM/C). Little formal education exists in medical, nursing or midwifery schools. Additionally, very few studies assess attitudes and knowledge of U.S. providers to care for these women. In order to eventually offer FGM/C-affected women informed and culturally competent care, assessments of provider readiness and attitudes must guide future educational efforts. Methods A voluntary survey was administered to healthcare providers prior to thirteen separate education sessions on FGM/C at Philadelphia institutions. Results Of the 229 surveys distributed, 227 were returned > 50% complete. 61.2% reported encountering FGM/C at least once in the past 5 years, yet 13.7% of participants reported receiving formal training in FGM/C; 77.5% felt unprepared and 47.1% uncomfortable serving patients with FGM/C. 34.1% of participants knew the matriarchal influence on the custom. The majority of providers accurately identified the short and long-term clinical consequences of FGM/C, but 67.7% of participants denied familiarity with laws regarding FGM/C. Attitude assessment revealed beliefs that all types of FGM/C are harmful and a practice rooted in tradition. Discussion While most providers reported encountering patients with FGM/C, lack of formal training leaves them unprepared and uncomfortable serving them. Results demonstrate misunderstanding of the tradition and motives of FGM/C. Our findings support the need for expansion of provider education to provide culturally competent care for women affected by FGM/C.
- 13 May 2020
- Published by Springer Nature in Journal of Immigrant and Minority Health
- Vol. 23 (1) , 45-53
Provider Knowledge and Attitudes About Female Genital Mutilation/Cutting in Philadelphia
Background Due to an increase in immigration from African countries, U.S. healthcare professionals are encountering women affected by Female Genital Mutilation/Cutting (FGM/C). Little formal education exists in medical, nursing or midwifery schools. Additionally, very few studies assess attitudes and knowledge of U.S. providers to care for these women. In order to eventually offer FGM/C-affected women informed and culturally competent care, assessments of provider readiness and attitudes must guide future educational efforts. Methods A voluntary survey was administered to healthcare providers prior to thirteen separate education sessions on FGM/C at Philadelphia institutions. Results Of the 229 surveys distributed, 227 were returned > 50% complete. 61.2% reported encountering FGM/C at least once in the past 5 years, yet 13.7% of participants reported receiving formal training in FGM/C; 77.5% felt unprepared and 47.1% uncomfortable serving patients with FGM/C. 34.1% of participants knew the matriarchal influence on the custom. The majority of providers accurately identified the short and long-term clinical consequences of FGM/C, but 67.7% of participants denied familiarity with laws regarding FGM/C. Attitude assessment revealed beliefs that all types of FGM/C are harmful and a practice rooted in tradition. Discussion While most providers reported encountering patients with FGM/C, lack of formal training leaves them unprepared and uncomfortable serving them. Results demonstrate misunderstanding of the tradition and motives of FGM/C. Our findings support the need for expansion of provider education to provide culturally competent care for women affected by FGM/C.
- 1 January 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 222 (1) , S406-S407
637: Does time of day of betamethasone administration affect neonatal outcomes?
- 1 January 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 222 (1) , S406-S407
637: Does time of day of betamethasone administration affect neonatal outcomes?
- 1 January 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 222 (1) , S273
416: The effect of cervical manipulation on fetal fibronectin result: a systematic review
- 1 January 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 222 (1) , S273
416: The effect of cervical manipulation on fetal fibronectin result: a systematic review
- 5 November 2019
- Published by Walter de Gruyter GmbH in Case Reports in Perinatal Medicine
- Vol. 9 (1)
Fetal head entrapment within the lower uterine segment
Fetal head entrapment by a uterine scar or adhesion is a rare obstetric complication. We present a case of a uterine constriction diagnosed in pregnancy that resulted in confinement of the fetal head to the lower uterine segment. The developing fetus ultimately suffered growth restriction of the head and was delivered after the mother experienced preterm premature rupture of membranes (PROM). Severe adhesions of the lower uterine segment were confirmed during the patient’s classical cesarean section.
- 5 November 2019
- Published by Walter de Gruyter GmbH in Case Reports in Perinatal Medicine
- Vol. 9 (1)
Fetal head entrapment within the lower uterine segment
Fetal head entrapment by a uterine scar or adhesion is a rare obstetric complication. We present a case of a uterine constriction diagnosed in pregnancy that resulted in confinement of the fetal head to the lower uterine segment. The developing fetus ultimately suffered growth restriction of the head and was delivered after the mother experienced preterm premature rupture of membranes (PROM). Severe adhesions of the lower uterine segment were confirmed during the patient’s classical cesarean section.